-
1
-
-
0024380940
-
Economic considerations that influence health policy and research
-
Harlan WR. Economic considerations that influence health policy and research. Hypertension 1989;13(supp 1):1-163.
-
(1989)
Hypertension
, vol.13
, Issue.SUPPL. 1
, pp. 1-163
-
-
Harlan, W.R.1
-
2
-
-
0009529718
-
-
Public Health Service, Series C, No 7, DHHS Publication No 89-20407. Washington DC: US Government Printing Office
-
Harlan WR, Thomas JW, Hurt HA, et al. Health Care Utilization and Costs of Adult Cardiovascular Disease, National Medical Care Utilization and Expenditure Survey. Public Health Service, Series C, No 7, DHHS Publication No 89-20407. Washington DC: US Government Printing Office, 1989.
-
(1989)
Health Care Utilization and Costs of Adult Cardiovascular Disease, National Medical Care Utilization and Expenditure Survey
-
-
Harlan, W.R.1
Thomas, J.W.2
Hurt, H.A.3
-
3
-
-
0028852699
-
Cost-effectiveness analysis in heart disease I: General principles
-
Kupersmith J, Holmes-Royner M, Hogan A, et al. Cost-effectiveness analysis in heart disease I: General principles. Prog Cardiovasc Dis 1995;37:243-71.
-
(1995)
Prog Cardiovasc Dis
, vol.37
, pp. 243-271
-
-
Kupersmith, J.1
Holmes-Royner, M.2
Hogan, A.3
-
4
-
-
0027849659
-
An evaluation of the cost of heart failure to the NHS in the UK
-
McMurray J. An evaluation of the cost of heart failure to the NHS in the UK. Br J Med Econ 1993;6:99-110.
-
(1993)
Br J Med Econ
, vol.6
, pp. 99-110
-
-
McMurray, J.1
-
5
-
-
0029986735
-
The pharmacoeconomics of ACE inhibitors in chronic heart failure
-
McMurray J, Davie A. The pharmacoeconomics of ACE inhibitors in chronic heart failure. PharmacoEconomics 1996;9:188-97.
-
(1996)
PharmacoEconomics
, vol.9
, pp. 188-197
-
-
McMurray, J.1
Davie, A.2
-
6
-
-
0028092116
-
A randomised trial of beta blockade in heart failure
-
CIBIS Investigators and Committees. A randomised trial of beta blockade in heart failure. Circulation 1994;90:1765-73.
-
(1994)
Circulation
, vol.90
, pp. 1765-1773
-
-
-
7
-
-
0031712952
-
A cost-minimization of heart failure therapy with bisoprolol in the french setting: An analysis from the CIBIS trial data
-
Levy P, Lechat P, Leizorovicz A, et al. A cost-minimization of heart failure therapy with bisoprolol in the french setting: An analysis from the CIBIS trial data. Cardiovasc Drug Ther 1998;12:301-5.
-
(1998)
Cardiovasc Drug Ther
, vol.12
, pp. 301-305
-
-
Levy, P.1
Lechat, P.2
Leizorovicz, A.3
-
8
-
-
0031983907
-
Economic evaluation of the CIBIS study for the Federal Republic of Germany
-
Schaedlich PK, Paschen B, Brecht JG. Economic evaluation of the CIBIS study for the Federal Republic of Germany. PharmacoEconomics 1998;13:147-55.
-
(1998)
PharmacoEconomics
, vol.13
, pp. 147-155
-
-
Schaedlich, P.K.1
Paschen, B.2
Brecht, J.G.3
-
10
-
-
0033514046
-
The cardiac insufficiency biroprolol study II (CIBIS II): A randomised trial
-
CIBIS II Investigators and Committees. The cardiac insufficiency biroprolol study II (CIBIS II): A randomised trial. Lancet 1999;353:9-13.
-
(1999)
Lancet
, vol.353
, pp. 9-13
-
-
-
11
-
-
0033028999
-
Cost effectiveness of carvedilol for heart failure
-
Delea TE, Vera-Llonch M, Richner RE, et al. Cost effectiveness of carvedilol for heart failure. Am J Cardiol 1999;83:890-6.
-
(1999)
Am J Cardiol
, vol.83
, pp. 890-896
-
-
Delea, T.E.1
Vera-Llonch, M.2
Richner, R.E.3
|